A history of drug advertising, from opium-laced tonics and Radithor to the 1938 law after Elixir Sulfanilamide killed over 100 people. Semaglutide is mostly a hook.
Recap by typeshit. Full story at Medical Marketing and Media.
The EMA's CHMP amended its type 2 diabetes indication, and Italian diabetologists say Italy could be the first European country to offer the once-weekly combo.
26:19
A personal update from TakingWeightOff on life after stopping tirzepatide, three weeks in, and what caught them off guard.
Nyah Phengsitthy reports Lilly is staking out a new battlefront around an unapproved obesity treatment. The full story has the details.
6:45
Kim Constable gives her take on peptides aimed at women past 40. Her claims are her own, so watch with that in mind.
Bikman says midface volume drops about 7% for every 10 kg lost, and that bariatric surgery patients see the same change.
In a JAMA Viewpoint, CSPI authors argue a peptide-friendly advisory panel stacked with industry-tied members threatens drug approval integrity.
Loading…